Clinical trial Recruiting at 5 sites Interventional Ages 2 to 65

VIPP-SD for Singapore: Improving Sensitive Parenting to Support Early Childhood Growth

Official title: LOVING (Learning About Our Behavior is Valuable for Increasing Nurturing Relationships and Healthy Growth)

Run by National University of Singapore · NCT07687524 · Data updated 2026-11-12

This trial tests whether adapting a proven parenting program (VIPP-SD) for Singapore improves how parents respond to their young children and helps emotional, behavioral, and cognitive development.

More Child Development trials

Quick facts

Study typeInterventional
Ages2 Years to 65 Years
SexAll
Enrollment624 (estimated)
SponsorNational University of Singapore
Academic / other
Locations5 sites (Singapore, Singapore and 4 other locations)
StatusRecruiting
StartedMay 25, 2026
Main results expectedFebruary 9, 2028
Study endsFebruary 9, 2028
Registry record updatedJuly 7, 2026
Trial IDNCT07687524 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2 to 5.5 years without major medical or developmental conditions that affect sight, hearing, movement, or communication; and their parents aged 21 to 65 who are primary caregivers and otherwise eligible.

Probably not a fit

Children with significant medical or developmental impairments that limit everyday interactions may not experience the intended benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial evaluates adaptations of the VIPP-SD program for Singapore, aiming to increase sensitive caregiving and examine downstream child outcomes in early childhood. It uses home-based video feedback to help caregivers recognize and respond to their child’s cues and to promote positive discipline. The study targets children aged 2 to 5.5 years and involves multiple Singaporean institutions to assess feasibility, applicability, and impact in an Asian context. Outcomes include child behavior, executive function, and related developmental indicators, alongside parental sensitivity measures.

Why it matters

Potential benefit: If successful, the program could enhance parent-child interactions and support healthier emotional, behavioral, and cognitive development in early childhood.

How similar studies have gone: Previous VIPP-SD trials in Europe and North America showed improvements in parenting sensitivity and some child outcomes, but evidence in Asian settings is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Children must be 2 to 5.5 years of age at their pre-test visit. Children with a medical or developmental condition that makes it hard for them to see, hear, move, or communicate in typical ways (for example, autism spectrum disorder, down syndrome, spina bifida, or serious vision or hearing problems) will not be eligible to participate. This is because the study focuses on everyday patterns of parent-child interaction. Children with minor or symptom-free medical or genetic conditions (for example, traits that do not affect their day-to-day health or development) can take part.

Parents must be between 21 and 65 years old at the time of consent. Mothers and fathers who consider themselves to have a major caregiving role are eligible. Parents who have been hospitalized for more than two weeks (inclusive) within the past 6 months and/or have had any in-patient mental health treatment within the past 6 months may not participate, nor may parents with notable neurodegenerative diagnosis such as Alzheimer's, Parkinson's, or Huntington's disease.

Participants must be from families earning near to Singapore's median household income or below, provided recruitment and enrollment difficulties have not triggered a pre-defined rule leading to the omission of this requirement. Parents and children must be able to communicate in English, Mandarin, Bahasu Melayu, and/or Tamil. Participants must also be willing to be audio-video recorded and amenable to random assignment.

Where it's running

  • Insitute of Human Development and Potential, Agency for Science and Technology Research (A*STAR)
    Singapore, Singapore, Singapore
    Recruiting
  • National University of Singapore
    Singapore, Singapore, Singapore
    Recruiting
  • KK Women and Children's Hospital
    Singapore, Singapore, Singapore
    Recruiting
  • National Institute of Education, Nanyang Technological University
    Singapore, Singapore, Singapore
    Recruiting
  • Nanyang Technological University
    Singapore, Singapore, Singapore
    Recruiting

Study contacts

  • Principal investigator: Anne E Rifkin-Graboi, PhD — National University of Singapore
  • Study coordinator: Christy Yifan Jiang, PhD
  • Email: jyifan@nus.edu.sg
  • Phone: 80695639

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.